AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,784,802 | -29.6% | 193,452 | -35.0% | 0.01% | -26.7% |
| Q2 2023 | $13,893,637 | +78.4% | 297,572 | +46.2% | 0.02% | +66.7% |
| Q1 2023 | $7,789,048 | +3377.8% | 203,582 | +4881.2% | 0.01% | – |
| Q4 2022 | $223,968 | -65.8% | 4,087 | -78.7% | 0.00% | -100.0% |
| Q3 2022 | $654,000 | +247.9% | 19,214 | -3.5% | 0.00% | – |
| Q2 2022 | $188,000 | -10.0% | 19,916 | -0.1% | 0.00% | – |
| Q1 2022 | $209,000 | -48.5% | 19,926 | +3.7% | 0.00% | – |
| Q4 2021 | $406,000 | -17.3% | 19,209 | -12.6% | 0.00% | – |
| Q3 2021 | $491,000 | -9.7% | 21,972 | +0.1% | 0.00% | -100.0% |
| Q2 2021 | $544,000 | -18.3% | 21,941 | -4.4% | 0.00% | 0.0% |
| Q1 2021 | $666,000 | +7.4% | 22,962 | -4.4% | 0.00% | 0.0% |
| Q4 2020 | $620,000 | -19.6% | 24,020 | -4.1% | 0.00% | 0.0% |
| Q3 2020 | $771,000 | -8.2% | 25,042 | -25.7% | 0.00% | 0.0% |
| Q2 2020 | $840,000 | -41.7% | 33,708 | -50.3% | 0.00% | 0.0% |
| Q1 2020 | $1,440,000 | +3900.0% | 67,888 | +4121.9% | 0.00% | – |
| Q4 2019 | $36,000 | -40.0% | 1,608 | -38.8% | 0.00% | – |
| Q3 2019 | $60,000 | +93.5% | 2,629 | +63.5% | 0.00% | – |
| Q2 2019 | $31,000 | – | 1,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
| venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
| Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
| Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
| Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
| Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
| Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
| Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
| HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |